Lung arginase expression and activity is increased in cystic fibrosis mouse models

Journal of Applied Physiology

Volumn 117, Issue 3, 2014, Pages 284-288

  Jaecklin, Thomas ^a,b   Duerr, Julia ^c   Huang, Hailu ^a   Rafii, Mahroukh ^a   Bear, Christine E ^a   Ratjen, Felix ^a,b   Pencharz, Paul ^a   Kavanagh, Brian P ^a,b   Mall, Marcus A ^c   Grasemann, Hartmut ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Arginase activity; Cystic fibrosis; Nitric oxide; Stable isotopes

Indexed keywords

ARGINASE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL; C57BL MOUSE; CYSTIC FIBROSIS; DISEASE MODEL; FEMALE; LUNG; LUNG DISEASE; MALE; METABOLISM; MOUSE; PNEUMONIA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; TRANSGENIC MOUSE;

ANIMALS; ARGINASE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; FEMALE; LUNG; LUNG DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PNEUMONIA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84905451913     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00167.2014     Document Type: Article

References (36)

1. Beharry S, Ackerley C, Corey M, Kent G, Heng YM, Christensen H, Luk C, Yantiss RK, Nasser IA, Zaman M, Freedman SD, Durie PR. Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis. Am J Physiol Gastrointest Liver Physiol 292:G839-G848, 2007.
2. Chapman AL, Morrissey BM, Vasu VT, Juarez MM, Houghton JS, Li CS, Cross CE, Eiserich JP. Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway. J Cyst Fibros 9:84-92, 2010.
3. Grasemann H, Ratjen F. Nitric oxide and l-Arginine deficiency in cystic fibrosis. Curr Pharm Des 18:726-736, 2012.
4. Grasemann H, Schwiertz R, Grasemann C, Vester U, Racké K, Ratjen F. Decreased systemic bioavailability of l-Arginine in patients with cystic fibrosis. Respir Res 7:87, 2006.
5. Grasemann H, Schwiertz R, Matthiesen S, Racké K, Ratjen F. Increased arginase activity in cystic fibrosis airways. Am J Respir Crit Care Med 172:1523-1528, 2005.
6. Grasemann H, Shehnaz D, Enomoto M, Leadley M, Belik J, Ratjen F. L-Ornithine derived polyamines in cystic fibrosis airways. PLos One 7:e46618, 2012.
7. Grasemann H, Tullis E, Ratjen F. A randomized controlled trial of inhaled l-Arginine in patients with cystic fibrosis. J Cyst Fibros 12:468-474, 2013.
8. Guilbault C, Martin P, Houle D, Boghdady ML, Guiot MC, Marion D, Radzioch D. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique. Lab Anim 39:336-352, 2005.
9. Guilbault C, Novak JP, Martin P, Boghdady ML, Saeed Z, Guiot MC, Hudson TJ, Radzioch D. Distinct pattern of lung gene expression in the Cftr-KO mice developing spontaneous lung disease compared with their littermate controls. Physiol Genomics 25:179-193, 2006.
10. Guilbault C, Saeed Z, Downey GP, Radzioch D. Cystic fibrosis mouse models. Am J Respir Cell Mol Biol 36:1-7, 2007.
11. Haston CK, McKerlie C, Newbigging S, Corey M, Rozmahel R, Tsui LC. Detection of modifier loci influencing the lung phenotype of cystic fibrosis knockout mice. Mamm Genome 13:605-613, 2002.
12. Jacobsen LC, Theilgaard-Mönch K, Christensen EI, Borregaard N. Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils. Blood 109:3084-3087, 2007.
13. Jaecklin T, Engelberts D, Otulakowski G, O'Brodovich H, Post M, Kavanagh BP. Lung-derived soluble mediators are pathogenic in ventilatorinduced lung injury. Am J Physiol Lung Cell Mol Physiol 300:L648-L658, 2011.
14. Kelley TJ, Drumm ML. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 102:1200-1207, 1998.
15. Kent G, Iles R, Bear CE, Huan LJ, Griesenbach U, McKerlie C, Frndova H, Ackerley C, Gosselin D, Radzioch D, O'Brodovich H, Tsui LC, Buchwald M, Tanswell AK. Lung disease in mice with cystic fibrosis. J Clin Invest 100:3060-3069, 1997.
16. Klasen S, Hammermann R, Fuhrmann M, Lindemann D, Beck KF, Pfeilschifter J, Racké K. Glucocorticoids inhibit lipopolysaccharideinduced up-regulation of arginase in rat alveolar macrophages. Br J Pharmacol 132:1349-1357, 2001.
17. Maarsingh H, Dekkers BG, Zuidhof AB, Bos IS, Menzen MH, Klein T, Flik G, Zaagsma J, Meurs H. Increased arginase activity contributes to airway remodelling in chronic allergic asthma. Eur Respir J 38:318-328, 2011.
18. Maarsingh H, Tio MA, Zaagsma J, Meurs H. Arginase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation. Respir Res 6:23, 2005.
19. Maarsingh H, Zuidhof AB, Bos IS, Van Duin M, Boucher JL, Zaagsma J, Meurs H. Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation. Am J Respir Crit Care Med 178:565-573, 2008.
20. Mall M, Grubb BR, Harkema JR, O'Neal WK, Boucher RC. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10:487-493, 2004.
21. Mall MA, Button B, Johannesson B, Zhou Z, Livraghi A, Caldwell RA, Schubert SC, Schultz C, O'Neal WK, Pradervand S, Hummler E, Rossier BC, Grubb BR, Boucher RC. Airway surface liquid volume regulation determines different airway phenotypes in liddle compared with betaENaC-overexpressing mice. J Biol Chem 285:26945-26955, 2010.
22. Mall MA, Harkema JR, Trojanek JB, Treis D, Livraghi A, Schubert S, Zhou Z, Kreda SM, Tilley SL, Hudson EJ, O'Neal WK, Boucher RC. Development of chronic bronchitis and emphysema in beta-epithelial Na+ channel-overexpressing mice. Am J Respir Crit Care Med 177:730-742, 2008.
23. Mehl A, Ghorbani P, Douda D, Huang H, Palaniyar N, Ratjen F, Grasemann H. Effect of arginase inhibition on pulmonary l-Arginine metabolism in murine Pseudomonas pneumonia. PLos One 9:e90232, 2014.
24. Mhanna MJ, Ferkol T, Martin RJ, Dreshaj IA, Van Heeckeren AM, Kelley TJ, Haxhiu MA. Nitric oxide deficiency contributes to impairment of airway relaxation in cystic fibrosis mice. Am J Respir Cell Mol Biol 24:621-626, 2001.
25. Mills CD. M1 and M2 macrophages: oracles of health and disease. Crit Rev Immunol 32:463-488, 2012.
26. Munder M, Mollinedo F, Calafat J, Canchado J, Gil-Lamaignere C, Fuentes JM, Luckner C, Doschko G, Soler G, Eichmann K, Müller FM, Ho AD, Goerner M, Modolell M. Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 105:2549-2556, 2005.
27. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:E45, 2001.
28. Racké K, Warnken M. L-Arginine metabolic pathways. Open Nitric Oxide J 2:9-19, 2010.
29. Sonoki T, Nagasaki A, Gotoh T, Takiguchi M, Takeya M, Matsuzaki H, Mori M. Coinduction of nitric-oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide. J Biol Chem 272:3689-3693, 1997.
30. Steagall WK, Elmer HL, Brady KG, Kelley TJ. Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression. Am J Respir Cell Mol Biol 22:45-50, 2000.
31. Tomlinson C, Rafii M, Ball RO, Pencharz P. Arginine synthesis from enteral glutamine in healthy adults in the fed state. Am J Physiol Endocrinol Metab 301:E267-E273, 2011.
32. Urschel KL, Rafii M, Pencharz PB, Ball RO. A multitracer stable isotope quantification of the effects of arginine intake on whole body arginine metabolism in neonatal piglets. Am J Physiol Endocrinol Metab 293:E811-E818, 2007.
33. Von Bethmann AN, Brasch F, Nüsing R, Vogt K, Volk HD, Müller KM, Wendel A, Uhlig S. Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med 157:263-272, 1998.
34. Waddington SN, Mosley K, Cook HT, Tam FW, Cattell V. Arginase AI is upregulated in acute immune complex-induced inflammation. Biochem Biophys Res Commun 247:84-87, 1998.
35. Wilson DC, Rafii M, Ball RO, Pencharz PB. Threonine requirement of young men determined by indicator amino acid oxidation with use of l-[1-(13) C]phenylalanine. Am J Clin Nutr 71:757-764, 2000.
36. Zhou Z, Duerr J, Johannesson B, Schubert SC, Treis D, Harm M, Graeber SY, Dalpke A, Schultz C, Mall MA. The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease. J Cyst Fibros 10, Suppl 2:S172-S182, 2011.